Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by 13PunterDogon Nov 19, 2015 10:00am
226 Views
Post# 24304833

RE:FDA Approval with Conditions in 2016?

RE:FDA Approval with Conditions in 2016?Approval in Feb 2016 with some sort of " patient refusal to cystectomy" condition. That's what the panel were getting at yesterday, I would say. I think about 6 or 8 panelists would have voted for it if this was in the question. No matter how you slice it , MCNA is the only drug out there now. Valrubicin (sp?) is worthless and MCNA is light years ahead of this FDA approved drug in efficacy and especially safety. That's what kills me.

FDA will do the politically correct thing and approve in Feb , as there is a dire unmet need for this. Maybe politically correctness can be in my favor for once in my life.

Oh well gotta wait a couple more months. I'm not going to look at this til after Xmas, giving me a headache.

GLTALongs

13PD


<< Previous
Bullboard Posts
Next >>